David C. Rubinsztein

116.2k citations
355 papers · 46.8k · 26 hit papers · h-index 109

Impact in

  • Physiology top 0.01%
    • Alzheimer's disease research and treatments
    • Calcium signaling and nucleotide metabolism
  • Aging top 0.1%

Papers in

    • Autophagy in Disease and Therapy 163
    • Mitochondrial Function and Pathology 68
    • Ubiquitin and proteasome pathways 31

David C. Rubinsztein

352 papers receiving 46.2k citations

David C. Rubinsztein's Hit Papers

Autophagy, aging, and age-related neurodegeneration 2024 · 61 citations
610+5+10Years since publication50010001.5k2.0k

Peers

David C. Rubinsztein
Comparison fields: 5 of 172
  • Physiology 4.0k
  • Aging 1.2k
  • Epidemiology 22.3k
  • Cell Biology 10.0k
  • Neurology 8.4k
Replace Ana María Cuervo with:
Ana María Cuervo United States
Richard J. Youle United States
Keiji Tanaka Japan
Masaaki Komatsu Japan
Andrea Ballabio Italy
Valina L. Dawson United States
Ted M. Dawson United States
Ralph A. Nixon United States
Junying Yuan United States
Dario R. Alessi United Kingdom
David C. Rubinsztein relative to Ana María Cuervo United States Ana María Cuervo's profile →
Citations per field
00.5×1.5×
Ana María Cuervo · 1×
Citations per year

Countries citing papers authored by David C. Rubinsztein

Since Specialization
Citations

This map shows the geographic impact of David C. Rubinsztein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Rubinsztein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Rubinsztein more than expected).

Fields of papers citing papers by David C. Rubinsztein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Rubinsztein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Rubinsztein. The network helps show where David C. Rubinsztein may publish in the future.

Co-authors

The 25 scholars most cited alongside David C. Rubinsztein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David C. Rubinsztein Line = papers co-authored together David C. Rubinsztein links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 355 papers — load more, or switch the sort, to bring in the rest.

#Work
1
TFEB Links Autophagy to Lysosomal Biogenesis
Hit paper breakdown →
20112496
2
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
Hit paper breakdown →
20041902
3
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
Hit paper breakdown →
20101427
4
The roles of intracellular protein-degradation pathways in neurodegeneration
Hit paper breakdown →
20061323
5
Autophagy modulation as a potential therapeutic target for diverse diseases
Hit paper breakdown →
20121188
6
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Hit paper breakdown →
20031171
7
Trehalose, a Novel mTOR-independent Autophagy Enhancer, Accelerates the Clearance of Mutant Huntingtin and α-Synuclein
Hit paper breakdown →
2006919
8
Potential therapeutic applications of autophagy
Hit paper breakdown →
2007864
9
Autophagy in healthy aging and disease
Hit paper breakdown →
2021798
10
Lithium induces autophagy by inhibiting inositol monophosphatase
Hit paper breakdown →
2005780
11
Plasma membrane contributes to the formation of pre-autophagosomal structures
Hit paper breakdown →
2010695
12
Lysosomal positioning coordinates cellular nutrient responses
Hit paper breakdown →
2011671
13
α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
Hit paper breakdown →
2010651
14
Compromised autophagy and neurodegenerative diseases
Hit paper breakdown →
2015649
15
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway
Hit paper breakdown →
2008638
16
Autophagy as a promoter of longevity: insights from model organisms
Hit paper breakdown →
2018549
17
Mammalian Autophagy: How Does It Work?
Hit paper breakdown →
2016547
18
Autophagy Inhibition Compromises Degradation of Ubiquitin-Proteasome Pathway Substrates
Hit paper breakdown →
2009533
19
Rapamycin alleviates toxicity of different aggregate-prone proteins
Hit paper breakdown →
2005532
20 2007474

About David C. Rubinsztein

David C. Rubinsztein is a scholar working on Epidemiology, Molecular Biology, Cellular and Molecular Neuroscience, Cell Biology and Neurology, having authored 355 papers that have together received 46.8k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (163 papers), Genetic Neurodegenerative Diseases (117 papers), Mitochondrial Function and Pathology (68 papers), Parkinson's Disease Mechanisms and Treatments (47 papers), Endoplasmic Reticulum Stress and Disease (38 papers), Cellular transport and secretion (34 papers), Lysosomal Storage Disorders Research (33 papers) and Ubiquitin and proteasome pathways (31 papers). The work is most often cited by research in Physiology (4.0k citations), Aging (1.2k citations), Epidemiology (22.3k citations), Cell Biology (10.0k citations) and Neurology (8.4k citations). David C. Rubinsztein has collaborated with scholars based in United Kingdom, United States and Malaysia. Frequent co-authors include Fiona M. Menzies, Brinda Ravikumar, Sovan Sarkar, Shouqing Luo, Cahir J. O’Kane, Kévin Moreau, Viktor I. Korolchuk, J. Eric Davies, Claudia Puri and Maurizio Renna. Their work appears in journals such as Autophagy, Human Molecular Genetics, Journal of Medical Genetics, Nature Communications and Journal of Cell Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact